Literature DB >> 18715994

Epigenetics, development, and the kidney.

Gregory R Dressler1.   

Abstract

How cells partition the genome into active and inactive genes and how that information is established and propagated during embryonic development are fundamental to maintaining the normal differentiated state. The molecular mechanisms of epigenetic action and cellular memory are increasingly amenable to study primarily as a result of the rapid progress in the area of chromatin biology. Methylation of DNA and modification of histones are critical epigenetic marks that establish active and silent chromatin domains. During development of the kidney, DNA-binding factors such as Pax2/8, which are essential for the intermediate mesoderm and the renal epithelial lineage, could provide the locus and tissue specificity for histone methylation and chromatin remodeling and thus establish a kidney-specific fate. The role of epigenetic modifications in development and disease is under intense investigation and has already affected our view of cancer and aging.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18715994     DOI: 10.1681/ASN.2008010119

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  28 in total

Review 1.  Fetal environment, epigenetics, and pediatric renal disease.

Authors:  Robert Woroniecki; Anil Bhanudas Gaikwad; Katalin Susztak
Journal:  Pediatr Nephrol       Date:  2010-12-21       Impact factor: 3.714

Review 2.  Fine tuning gene expression: the epigenome.

Authors:  Davoud Mohtat; Katalin Susztak
Journal:  Semin Nephrol       Date:  2010-09       Impact factor: 5.299

Review 3.  Systems biology of kidney diseases.

Authors:  John Cijiang He; Peter Y Chuang; Avi Ma'ayan; Ravi Iyengar
Journal:  Kidney Int       Date:  2011-08-31       Impact factor: 10.612

Review 4.  Epigenetic modifications in the pathogenesis of diabetic nephropathy.

Authors:  Marpadga A Reddy; Jung Tak Park; Rama Natarajan
Journal:  Semin Nephrol       Date:  2013-07       Impact factor: 5.299

5.  Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cells.

Authors:  Hang Yuan; Marpadga A Reddy; Guangdong Sun; Linda Lanting; Mei Wang; Mitsuo Kato; Rama Natarajan
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-12

Review 6.  PAX2 in human kidney malformations and disease.

Authors:  Lyndsay A Harshman; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2011-12-03       Impact factor: 3.714

7.  Tet3-mediated hydroxymethylation of epigenetically silenced genes contributes to bone morphogenic protein 7-induced reversal of kidney fibrosis.

Authors:  Björn Tampe; Desiree Tampe; Claudia A Müller; Hikaru Sugimoto; Valerie LeBleu; Xingbo Xu; Gerhard A Müller; Elisabeth M Zeisberg; Raghu Kalluri; Michael Zeisberg
Journal:  J Am Soc Nephrol       Date:  2014-01-30       Impact factor: 10.121

Review 8.  Epigenetic control of skeletal muscle regeneration: Integrating genetic determinants and environmental changes.

Authors:  Lorenzo Giordani; Pier Lorenzo Puri
Journal:  FEBS J       Date:  2013-07-15       Impact factor: 5.542

9.  Genome-wide analysis of gestational gene-environment interactions in the developing kidney.

Authors:  Lei Yan; Xiao Yao; Dimcho Bachvarov; Zubaida Saifudeen; Samir S El-Dahr
Journal:  Physiol Genomics       Date:  2014-07-08       Impact factor: 3.107

Review 10.  Renin-angiotensin system in ureteric bud branching morphogenesis: implications for kidney disease.

Authors:  Ihor V Yosypiv
Journal:  Pediatr Nephrol       Date:  2013-09-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.